%PDF-1.7
%
1 0 obj
<>>>
endobj
2 0 obj
<>stream
2017-03-10T09:07:38-05:00
2017-03-10T09:08:18-05:00
2017-03-10T09:08:18-05:00
Adobe InDesign CC 2017 (Windows)
uuid:5c163702-6d60-4030-ba19-7f9de1d5f099
xmp.did:4A42F9656056E111960DCE8E95F0DF9D
xmp.id:8184e9d3-d459-ba44-b67a-34aab5e82488
proof:pdf
xmp.iid:d2ab4102-dfdb-2343-9a12-258fdb4569d3
xmp.did:6044a9ec-5312-2a42-89ca-589913034d88
xmp.did:4A42F9656056E111960DCE8E95F0DF9D
default
converted
from application/x-indesign to application/pdf
Adobe InDesign CC 2017 (Windows)
/
2017-03-10T09:07:38-05:00
application/pdf
Adobe PDF Library 15.0
False
endstream
endobj
3 0 obj
<>
endobj
5 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
6 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC/ImageI]/XObject<>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
18 0 obj
<>stream
BT
0 0 0 1 k
/GS0 gs
/TT0 1 Tf
7 0 0 7 60.48 22.6817 Tm
(2 )Tj
/Span<>> BDC
( )Tj
EMC
56.231 0 Td
[(Clinical Briefs in P)18.1 (rimary Care)]TJ
ET
q
0 g
/GS1 gs
0 TL/Fm0 Do
Q
BT
/T1_0 1 Tf
-0.01 Tc 7 0 0 7 40.75 373.76 Tm
(CLINICAL BRIEFS IN PRIMARY CARE)Tj
/T1_1 1 Tf
0 Tc 6 0 0 6 158.4884 373.76 Tm
(\231 )Tj
1.23 0 Td
( )Tj
-0.01 Tc -20.853 -1.167 Td
[(is published monthly by AHC Media, a Relias Learning)-10 ( )]TJ
0 -1.167 TD
[(company. Copyright \251 2017 AHC Media, a Relias Learning)-10 ( )]TJ
0.01 Tw 0 -1.167 TD
[(company.)-10 ( )]TJ
/T1_2 1 Tf
8 0 0 8 40.75 342.76 Tm
(Editor:)Tj
/T1_1 1 Tf
0 Tw ( Jonathan Springston)Tj
/T1_2 1 Tf
0 -1.25 TD
(Executive Editor:)Tj
/T1_1 1 Tf
( Leslie Coplin)Tj
/T1_2 1 Tf
T*
(Physician Editor:)Tj
/T1_1 1 Tf
( Stephen Brunton, MD)Tj
6 0 0 6 40.75 308.76 Tm
[(This is an educational publication designed to present)-10 ( )]TJ
0 -1.167 TD
[(scientific information and opinion to health professionals,)-10 ( )]TJ
0 -1.167 TD
[(stimulate thought, and further investigation. It does not)-10 ( )]TJ
0 -1.167 TD
[(provide advice regarding medical diagnosis or treatment)-10 ( )]TJ
T*
(for any individual case. It is not intended for the layman.)Tj
0.01 Tc 0 -1.917 TD
(STATEMENT OF FINANCIAL DISCLOSURE)Tj
-0.025 Tc 0 -1.167 TD
[(To reveal any potential bias in this publication, and in)-25 ( )]TJ
-0.001 Tw T*
[(accordance with Accreditation Council for Continuing Medical)-25 ( )]TJ
0 Tw 0 -1.167 TD
[(Education guidelines, Dr. Brunton reports he is a retained)-25 ( )]TJ
0 -1.167 TD
[(consultant for Abbott Diabetes, Actavis, AstraZeneca, Becton)-25 ( )]TJ
T*
[(Dickinson, Boehringer Ingelheim, Cempra, Janssen, Lilly,)-25 ( )]TJ
0 -1.167 TD
[(Merck, Novo Nordisk, Sanofi, and Teva; he serves on the)-25 ( )]TJ
0 -1.167 TD
[(speakers bureau of AstraZeneca, Boehringer Ingelheim,)-25 ( )]TJ
T*
[(Janssen, Lilly, Novo Nordisk, and Teva. Dr. Kuritzky \(author\))-25 ( )]TJ
0 -1.167 TD
[(is a retained consultant for and on the speakers bureau of)-25 ( )]TJ
0 -1.167 TD
[(Allergan, Daiichi Sankyo, Lilly, and Lundbeck. Ms. Coplin and)-25 ( )]TJ
T*
[(Mr. Springston report no financial relationships relevant to this)-24.9 ( )]TJ
0 -1.167 TD
(field of study.)Tj
ET
/CS0 CS 1 SCN
0.25 w 4 M
/GS1 gs
36.125 45.125 165.734 338.51 re
S
/CS0 cs 0.1 scn
43.545 106.88 146.91 68.76 re
f
0.86 0.57 0 0.16 K
0.3 w 10 M
q 1 0 0 1 85.6163 146.0642 cm
0 0 m
80.087 0 l
S
Q
q 1 0 0 1 72.6205 139.0642 cm
0 0 m
42.017 0 l
S
Q
BT
0 0 0 1 k
/GS0 gs
/T1_2 1 Tf
0.05 Tc 8 0 0 8 48.0448 163.9401 Tm
[(SUBSCRIBER INFORMA)92 (TION)]TJ
-0.01 Tc 7 0 0 7 48.0448 153.6641 Tm
(Customer Service: \(800\) 688-2421)Tj
/T1_1 1 Tf
-0.025 Tc 6 0 0 6 48.0448 146.6641 Tm
(Email Address:)Tj
0.86 0.57 0 0.16 k
/GS1 gs
( jspringston@reliaslearning.com)Tj
0 0 0 1 k
/GS0 gs
-0.01 Tc 0.01 Tw 0 -1.167 TD
(Website: )Tj
0.86 0.57 0 0.16 k
/GS1 gs
4.096 0 Td
(AHCMedia.com)Tj
0 0 0 1 k
/GS0 gs
0 Tw -4.096 -1.917 Td
[(Address Correspondence to: AHC Media, a Relias)-10 ( )]TJ
T*
[(Learning company, 111 Corning Road, Suite 250,)-10 ( )]TJ
T*
[(Cary, NC 27518.)-10 ( )]TJ
ET
q
81.64 94 68.84 -38.25 re
W n
q
/GS1 gs
68.8401276 0 0 38.2499963 81.6398926 55.7500113 cm
/Im0 Do
Q
Q
/CS0 CS 1 SCN
1 w
/GS1 gs
q 1 0 0 1 36 569.7798 cm
0 0 m
165.984 0 l
S
Q
q 1 0 0 1 36 534.7418 cm
0 0 m
165.984 0 l
S
Q
BT
/GS0 gs
/T1_3 1 Tf
0.015 Tc 9 0 0 9 36 737.0496 Tm
[(This survey found that 4.3% of adults)15 ( )]TJ
0 -1.204 TD
[(ful\037lled criteria for antisocial personality)15 ( )]TJ
0 -1.204 TD
[(disorder)111 (. Rates were highest in younger)15 ( )]TJ
0 -1.204 TD
(adult white and Native American males.)Tj
0 -2.408 TD
[(T)67 (reatments for antisocial personality)15 ( )]TJ
0 -1.204 TD
[(disorder are labor intensive. Antisocial)15 ( )]TJ
0 -1.204 TD
[(personality disorder tends to remit over)15 ( )]TJ
-0.015 Tw T*
[(time.)15 ( )]TJ
0 Tw 0 -2.408 TD
[(Whether treatment for the numerous)15 ( )]TJ
0 -1.204 TD
[(other comorbidities, such as substance)15 ( )]TJ
T*
(abuse associated with antisocial person)Tj
0 Tc (-)Tj
0.015 Tc T*
[(ality disorder)111 (, will hasten time to remis)]TJ
0 Tc (-)Tj
0.015 Tc T*
[(sion is an area of needed research. )15 ( )]TJ
/CS0 cs 1 scn
/GS1 gs
/C2_0 1 Tf
0 Tc 10 0 0 10 178.2525 585.3177 Tm
<0084>Tj
0 0 0 1 k
/GS0 gs
/TT0 1 Tf
-0.005 Tc 14 0 0 14 36 555.7798 Tm
[(Atopic Dermatitis Associated)-5.1 ( )]TJ
0 -1.146 TD
(with Autoimmune Disorders)Tj
/TT1 1 Tf
0 Tc 9 0 0 9 36 516.9038 Tm
(SOURCE: Andersen YM, Egeberg A, Gisla)Tj
16.211 0 Td
(-)Tj
-16.211 -1.204 Td
[(son GH)17.8 (, et al. Autoimmune diseases in adults )]TJ
0 -1.204 TD
(with atopic dermatitis. )Tj
/TT2 1 Tf
8.647 0 Td
[(J Am A)-18.2 (cad Dermatol)]TJ
/TT1 1 Tf
( )Tj
-8.647 -1.204 Td
(2017;76:274-280.)Tj
/TT0 1 Tf
30.3235 0 0 30.3235 36.6663 453.7519 Tm
(A)Tj
/T1_3 1 Tf
0.015 Tc 9 0 0 9 56.0141 464.5519 Tm
[(topic dermatitis has been viewed)15 ( )]TJ
0 Tc 14.829 0 Td
( )Tj
0.015 Tc -14.829 -1.2 Td
( as a disorder of immune regula)Tj
0 Tc (-)Tj
0.015 Tc -2.224 -1.204 Td
[(tion primarily involving T)104 (-helper cells.)15 ( )]TJ
T*
(The common association between a)Tj
-0.015 Tw [(topic)15 ( )]TJ
T*
(dermatitis)Tj
0 Tw [(, asthma, and allergic rhinitis)15 ( )]TJ
T*
(supports the concept of shared immu)Tj
0 Tc (-)Tj
ET
/GS1 gs
q 1 0 0 1 214.008 414.1747 cm
0 0 m
165.984 0 l
S
Q
q 1 0 0 1 214.008 379.0032 cm
0 0 m
165.984 0 l
S
Q
BT
/GS0 gs
0.015 Tc 9 0 0 9 214.008 737.0496 Tm
[(nologic abnormalities. But the list of)15 ( )]TJ
0 -1.219 TD
(autoimmune disorders linked with a)Tj
-0.015 Tw [(topic)15 ( )]TJ
T*
(dermatitis)Tj
0 Tw ( has expanded to include vit)Tj
0 Tc (-)Tj
0.015 Tc 0 -1.219 TD
[(iligo, alopecia, lupus, and in\036ammatory)15 ( )]TJ
0 -1.219 TD
(bowel disease.)Tj
0 -2.438 TD
[(The Danish National Patient Registry)15 ( )]TJ
0 -1.219 TD
[(provides a window of observation into)15 ( )]TJ
0 -1.219 TD
[(the association of atopic dermatitis with)15 ( )]TJ
0 -1.219 TD
[(other autoimmune disorders. All Danes)15 ( )]TJ
0 -1.219 TD
(receive lifetime universal health insur)Tj
0 Tc 16.53 0 Td
(-)Tj
0.015 Tc -16.53 -1.219 Td
[(ance, and the registries represent both)15 ( )]TJ
0 -1.219 TD
(inpatient and outpatient data.)Tj
0 -2.438 TD
[(Based on hospital discharge diagnoses)15 ( )]TJ
0 -1.219 TD
[(of atopic dermatitis \(n = 8,112\) in the)15 ( )]TJ
T*
[(1997-2012 interval, an association of)15 ( )]TJ
T*
(atopic dermatitis was found with auto)Tj
0 Tc (-)Tj
0.015 Tc T*
[(immune disorders as well as urticaria,)15 ( )]TJ
T*
[(celiac disease, Sjogren\222)74 (s syndrome,)15 ( )]TJ
T*
[(ankylosing spondylitis, and rheumatoid)15 ( )]TJ
T*
(arthritis. These associations were stron)Tj
0 Tc (-)Tj
0.015 Tc 0 -1.219 TD
(ger among smokers.)Tj
0 -2.438 TD
[(Of course, association does not prove)15 ( )]TJ
0 -1.219 TD
[(causation. Hopefully)92 (, the immunologic)15 ( )]TJ
T*
[(links between these disorders will)15 ( )]TJ
T*
[(provide keys to their successful)15 ( )]TJ
-0.015 Tw T*
(management. )Tj
/CS0 cs 1 scn
/GS1 gs
/C2_0 1 Tf
0 Tc 0 Tw 10 0 0 10 272.4714 429.8463 Tm
<0084>Tj
0 0 0 1 k
/GS0 gs
/TT0 1 Tf
-0.005 Tc 14 0 0 14 214.008 400.1747 Tm
[(Sickle Cell T)175 (rait Falsely)-4.9 ( )]TJ
0 Tc 9.219 0 Td
( )Tj
-0.005 Tc -9.219 -1.155 Td
(Lowers Hemoglobin A1c)Tj
/TT1 1 Tf
0 Tc 9 0 0 9 214.008 361.0316 Tm
[(SOURCE: L)17.3 (acy ME, W)54.9 (ellenius GA, Sumner )]TJ
T*
(AE, et al. Association of sickle cell trait with )Tj
T*
(hemoglobin A1c in African Americans. )Tj
/TT2 1 Tf
(JAMA)Tj
/TT1 1 Tf
( )Tj
T*
(2017;317:507-515.)Tj
/TT0 1 Tf
30.3235 0 0 30.3235 213.8007 297.3455 Tm
(T)Tj
/T1_3 1 Tf
0.015 Tc 9 0 0 9 232.8376 308.1455 Tm
[(he recent endorsement of A1c)15 ( )]TJ
0 -1.2 TD
[(measurements for the diagnosis of)15.1 ( )]TJ
-2.092 -1.219 Td
(diabetes \(and prediabetes\) has engen)Tj
0 Tc (-)Tj
0.015 Tc 0 -1.219 TD
[(dered an increasingly frequent diagnosis)15 ( )]TJ
T*
[(of both disorders in symptomatic and)15 ( )]TJ
T*
[(asymptomatic individuals.)15 ( )]TJ
0 -2.438 TD
(A1c accurately re\036ects the average expo)Tj
0 Tc (-)Tj
0.015 Tc 0 -1.219 TD
[(sure of hemoglobin in red blood cells to)15 ( )]TJ
T*
[(glucose over the prior 90 days.)15 ( )]TJ
0 -2.438 TD
[(However)111 (, if red blood cell life is fore)]TJ
0 Tc (-)Tj
0.015 Tc 0 -1.219 TD
(shortened \227 as in hemoglobin S, hemo)Tj
0 Tc (-)Tj
0.015 Tc 0 -1.219 TD
[(globin C, thalassemia, hemolytic anemia,)15 ( )]TJ
0 -1.219 TD
[(sickle cell disease, and others \227 there)15 ( )]TJ
T*
[(is insuf\037cient red blood cell lifespan for)15 ( )]TJ
0 -1.219 TD
[(full glycosylation to occur)111 (, resulting in a)15 ( )]TJ
0 -1.219 TD
(reduced A1c level that does not accu)Tj
0 Tc (-)Tj
0.015 Tc 0 -1.219 TD
[(rately re\036ect long-term ambient glucose)15 ( )]TJ
T*
[(exposure. Might sickle cell trait affect)15 ( )]TJ
-0.015 Tw T*
(A1c?)Tj
0 Tw 0 -2.438 TD
[(Lacy et al performed a retrospective)15 ( )]TJ
0 -1.219 TD
[(cohort study from a sample of adults)15 ( )]TJ
T*
[(\(n = 4,620\) that included both A1c and)15 ( )]TJ
ET
/GS1 gs
q 1 0 0 1 392.016 534.8617 cm
0 0 m
165.984 0 l
S
Q
q 1 0 0 1 392.016 499.6902 cm
0 0 m
165.984 0 l
S
Q
BT
/GS0 gs
9 0 0 9 392.016 737.0496 Tm
[(plasma glucose levels. They found that)15 ( )]TJ
T*
[(the presence of prediabetes and diabetes)15 ( )]TJ
T*
[(was underestimated substantially when)15 ( )]TJ
0 -1.219 TD
[(A1c was the diagnostic tool in persons)15 ( )]TJ
0 -1.219 TD
[(with sickle cell trait.)15 ( )]TJ
0 -2.438 TD
[(The presence of sickle cell trait appears)15 ( )]TJ
0 -1.219 TD
[(to lead to lesser levels of hemoglobin)15 ( )]TJ
0 -1.219 TD
[(glycosylation than occurs in control)15 ( )]TJ
0 -1.219 TD
[(subjects. The mechanism for this effect)15 ( )]TJ
0 -1.219 TD
[(is controversial, but may re\036ect reduced)15 ( )]TJ
0 -1.219 TD
(red blood cell lifespan.)Tj
0 -2.438 TD
(Clinicians may wish to include addition)Tj
0 Tc (-)Tj
0.015 Tc 0 -1.219 TD
[(al diagnostic tests for diabetes in persons)15 ( )]TJ
T*
[(with sickle cell trait, such as fasting)15 ( )]TJ
T*
[(glucose, postprandial glucose, or oral)15 ( )]TJ
T*
[(glucose tolerance testing. )15 ( )]TJ
/CS0 cs 1 scn
/GS1 gs
/C2_0 1 Tf
0 Tc 10 0 0 10 497.5308 550.5333 Tm
<0084>Tj
0 0 0 1 k
/GS0 gs
/TT0 1 Tf
-0.005 Tc 14 0 0 14 392.016 520.8617 Tm
[(Hate T)175 (raffic? Y)109.8 (ou Might Be)-4.8 ( )]TJ
0 -1.155 TD
(Forgetting Something)Tj
/TT1 1 Tf
0 Tc 9 0 0 9 392.016 481.7187 Tm
[(SOURCE: Chen H)17.5 (, Kwong JC, Copes R, et al. )]TJ
0 -1.219 TD
(Living near major roads and the incidence of )Tj
T*
[(dementia, P)54.2 (arkinson)54.5 (\222s disease, and multiple scle)]TJ
17.998 0 Td
(-)Tj
-17.998 -1.219 Td
[(rosis: A population-based cohort study)85.8 (. )]TJ
/TT2 1 Tf
[(L)17.6 (ancet)]TJ
/TT1 1 Tf
( )Tj
T*
(2017;389:718-726.)Tj
/TT0 1 Tf
30.3235 0 0 30.3235 392.6823 407.0609 Tm
(A)Tj
/T1_3 1 Tf
0.015 Tc 9 0 0 9 412.0301 417.8609 Tm
[(s we search for remediable)15 ( )]TJ
0 Tc 12.127 0 Td
( )Tj
0.015 Tc -12.127 -1.2 Td
[( explanations for Alzheimer\222)74 (s)15 ( )]TJ
-2.224 -1.219 Td
[(disease and other dementias, several)15 ( )]TJ
T*
[(epidemiologically intriguing potential)15 ( )]TJ
T*
[(culprits have emerged, including air)15 ( )]TJ
T*
[(pollution and diesel exhaust. Although)15 ( )]TJ
0 -1.219 TD
[(such pollutants have been shown)15 ( )]TJ
0 -1.219 TD
[(to increase neuro-in\036ammation and)15 ( )]TJ
0 -1.219 TD
[(oxidative stress, neither of these effects is)15 ( )]TJ
0 -1.219 TD
[(suf\037cient evidence to de\037nitively convict)15 ( )]TJ
-0.015 Tw 0 -1.219 TD
(them.)Tj
0 Tw 0 -2.438 TD
[(Chen et al performed an analysis of)15 ( )]TJ
0 -1.219 TD
[(new onset dementia cases \(n = 243,611\))15 ( )]TJ
T*
[(in Canada to determine whether there)15 ( )]TJ
T*
[(was an association between how close)15 ( )]TJ
T*
[(one lives to a highway and incident)15 ( )]TJ
-0.015 Tw T*
(dementia.)Tj
0 Tw 0 -2.438 TD
[(The adjusted hazard ratio indicated)15 ( )]TJ
0 -1.219 TD
[(a slight increased risk for new onset)15 ( )]TJ
T*
[(dementia in people who lived < 50)15 ( )]TJ
T*
[(meters from a major road \(hazard ratio,)14.9 ( )]TJ
T*
[(1.07\) and a smaller)111 (, but still signi\037cant,)15 ( )]TJ
T*
[(increased risk among persons who lived)15 ( )]TJ
0 -1.219 TD
[(50-100 meters away \(hazard ratio, 1.04\).)15 ( )]TJ
0 -1.219 TD
(The relationship was strongest for per)Tj
0 Tc 16.907 0 Td
(-)Tj
0.015 Tc -16.907 -1.219 Td
[(sons who lived in major cities and lived)15 ( )]TJ
0 -1.219 TD
[(in the same site long term.)15 ( )]TJ
0 -2.438 TD
[(Although it\222)74 (s unlikely anyone anticipates)15 ( )]TJ
0 -1.219 TD
[(that these 4-7% relative risk increases)15 ( )]TJ
0 -1.219 TD
[(are dominant factors in the development)15 ( )]TJ
0 -1.219 TD
[(of dementia, perhaps they can provide)15 ( )]TJ
T*
[(mechanistic clues to the disease. )15 ( )]TJ
/CS0 cs 1 scn
/GS1 gs
/C2_0 1 Tf
0 Tc 10 0 0 10 525.4663 44.9999 Tm
<0084>Tj
ET
endstream
endobj
19 0 obj
<>
endobj
24 0 obj
<>>>/Subtype/Form>>stream
0 0 0 1 K
3 w 4 M 0 j 0 J
/GS0 gs
q 1 0 0 1 18 754.5 cm
0 0 m
558 0 l
S
Q
endstream
endobj
25 0 obj
<>stream
How,~ FQm
-lUEhʣm
J(q mLR>TThEU5Mm'FiZPllCٙٝǾL~gs̹(iEOT?QQDEOT?QQDEOT?QQDEOT?QQDEOT?QQDEOT?QQDEOT?QQDEOT?QQDEOT?QQDEOT?QQDEOT?QQDEOT?QQDEOT?QQDEOT?QQDEOT?Q=xK<ۛљu
5+VR%26FdvqycOi[hBYe\o %e̹, V/Pq'ņB/si-lٌ[.]8⏝+L#7̛Ӌ?$s\OmfO۴kJu
,3eEϏt$/!i*L~cqMb9G&?e?+IyQ{zƔo]Rz(\W^Dy*3~i`ĸYWo٩B+(a`ָ-`Ju_ݾRƙk][|y'[lͺi㧍\,Kۓ"D#0Qhd}=`ExZlm KC}}-7tհ
NlgY]]]c?JcCn\*wYwLI]kbc$/]oUpT`Z4>?NAHOK4[RY.rOV5
ߘ~/jOKYk/
N.4x/ ks)`նGad?7U{!Dna}&C{3ꔜ86&~4r0>>𗗗;WK*f';;
0.@}{% @C_5sm8?>>6>֖btbs>hƺ6NhUgȵa&Zw8ũS-?{{i}[i 0kpW1~K|aTJR0j.W➦ ج*2Gm+%}2bjj#~DVR7d"G(-~72q,h-AMJ _ 7$x0˷G
w^Hz
=h1?2MdŔw"SSbѹlj
B2w>6v2
aaH~уƟ[78Gna
ۤ0Js;rrkReeq='|~M^PϓQ4l%:UEw hl(/\AԔ
S_V*~thA`eH)|Ξ)ߌ/WړLt0Ib7S_7`w{{{&P.طvT`̶trsZr%%I<ĥb4Q#eՂEwe^o5EW"HofL@ec0|ewX3'Ebc\'t̿Z!rX#DSoP7շ!4lzr0MLgÆ{fK]$߃73GF/e\x,n":0Ws!Tp
L}PzyꐦZ3#MM!
IC?q=?yrRsi<ݟ%xnZĿ@NP"2I|kmV\>''p5NƟjFmiO]G2 TT(v E`agVe= hh=u%HQ؈.*,jg;3xT ~NĂAW{4bG*Du_C:@aFީ3+B݄iͪp-|
2(J0gJ(S,Ma}@S:%~=k7l< ,:R#M,+_u/
֗ޟyy;b`qQ+EIX2d(I~7*g{!Ze7qC0tݪ5웨2^(?H AagP]֯ohg=Z+MU2ɹᾘ,K={8ϯzFtj(U5) !Ѡ|* (U
8'Uj34"W0υv[nATVvu#Ud9S,&~T
vv_[8р/~*K
~5anٯW+=~mOiö×[GEO!o
~Ӱws
_@?N/s!UF=GpR6ajƽ,,G" $hs?G}:.CXϖoҹ}At/8EDPdm%FZdtMPitڷfZdq0"*QQ
=r=/U7t9{{E6ww}}֢H%GN#^1Rd0km
1tSd>m(IB7VuX%OOnR~.Ϻlr_/HSO- ԺzF"O@-&DZ1'o=}E|j}WqOB_a`[z(P+ro/r68C\gu lzX'I;$W12LnjyǓsOu?e2dKIoǞ~d] RVAϺ2]$y^@Iؘ,c:_Lom$7Wlo.2M?QI^$rǟ3|[
[G,|2۟KlAvHO(~jc%AK7yi2%igZIV(חmI]9WYI$,lɽ=ɵ!U]؏P>r
OzZ'ѻ!MqȤ+GI}nhZM. b_}
$DMe^G;^gδ26dk5 yr;Ώnb
VuX7ل^Jl~WvO!V4˪2RL
/}"dƟ.ԧVt2M5UjJn&.{3/ūyxmڊEPeu>N:[7A
7554z먎_|&6G>L?ZD};~&ף,|ȲzM]xze5;#4p@6Y}2XgarDOWjG9'?t5t"gcԹBnq XF:5@Px/{25~#2ü;2h} /]ۻ4WJu{G#bhnV?^[
uVf^H)㇇at621Ift7N'U6KjLq`՞?tɾٺ;vhiL}l
Q _vqUR"p_dqTL
P8c{x٤(窎271%LeHː E;کe3 LRkG!n0glJtNkmHCQi
{$%{W{vٛT_yw